Skip to main
  1. Stocks
  2. SkinHealth Systems Inc
  3. Forecast
SKIN

SKIN Stock Forecast & Price Target

SKIN Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 25%
Buy 0%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

SkinHealth Systems is positioned for improvement because management is attacking its main growth bottleneck in Delivery Systems through better sales-force execution, corporate account expansion, and a new U.S. rental program that should reduce provider financing friction and support installed-base growth. Its core strength remains the recurring consumables franchise, which returned to +1.2% growth in 3Q, accounted for 73% of revenue in 2Q26, and benefits from launches like HydraScalp, SkinStylus growth of 39% in 3Q, and a 36,516-system installed base. Even with continued EMEA weakness and competitive pressure, profitability is improving materially, with 3Q revenue of $69.2mm, gross margin of 71.8%, and adjusted EBITDA margin of 19.3%, while upcoming 2027 and 2028 product catalysts add longer-term upside.

Bears say

SkinHealth Systems is facing a deteriorating fundamental setup because Delivery Systems sales remain weak, falling -9.6% y/y to $18.8mm and -18% y/y in 2Q, while installed-base productivity is poor, with 770 placements yielding only 97 net additions. The recently launched U.S. rental program may ease provider financing barriers, but adoption is early and was not a meaningful contributor to 3Q, leaving utilization, consumables demand, and provider loyalty pressured amid ongoing Syndeo execution risk. With FY26 revenue guidance lowered, 3Q26 revenue expected at $65-70MM and adj. EBITDA at $5-7MM, and a $250MM November 2028 convertible maturity looming, visibility into a sustained recovery remains limited.

SKIN has been analyzed by 4 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 0% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SkinHealth Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

SKIN Analyst Forecast & Price Prediction

Get the latest SKIN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in SKIN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SkinHealth Systems Inc (SKIN) Forecast

Analysts have given SKIN a Hold based on their latest research and market trends.

According to 4 analysts, SKIN has a Hold consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SkinHealth Systems Inc (SKIN)


SKIN Analyst Forecast & Price Prediction

Get the latest SKIN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in SKIN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover SKIN stock data and trends